Austrian Federal Office for Safety in Health Care
Recent updates
Here you can find new page content of the last 4 weeks.
Safety information on communicable diseases (e.g. WNV, dengue) can be found here.
News
"Medikamente Info Austria" provides compact medication information in a new design Top-News
messages in brief
|
10/02/2026
The new medicines information system of the Federal Office for Safety in Health Care (BASG) went live on 10 February 2026. The previous information from the "Medicinal product index", the "Shortages index", the"Export ban index", the "BASG announcements" and the "BASG votes" will be merged into a compact medicines information portal at medikamente.basg.gv.at.
"Medikamente Info Austria" provides compact medication information in a new design
Read more
European Sperm Bank ApS – Donor: 45056/Sebastian New
Blood & Tissue
|
01/07/2026
The donor/donor gametes have been permanently blocked.
European Sperm Bank ApS – Donor: 45056/Sebastian
Read more
Avoidance of licensing infringements New
messages in brief
|
01/07/2026
Please note the to avoid licensing infrigements when you provide accessible texts.
Avoidance of licensing infringements
Read more
Current issue of “RMS NEWS” New
messages in brief
|
30/06/2026
Here you will find interesting news and links to current RMS-relevant topics.
Current issue of “RMS NEWS”
Read more
European Sperm Bank ApS – Donor: 26083/Selgen New
Safety warnings
|
Blood & Tissue
|
30/06/2026
The donor/donor gametes have been permanently blocked.
European Sperm Bank ApS – Donor: 26083/Selgen
Read more
Candeblo plus HCT 8 mg/12,5 mg - Tabletten New
Recall
|
Medicines
|
25/06/2026
Recall due to defective tablet quality
Candeblo plus HCT 8 mg/12,5 mg - Tabletten
Read more
European Sperm Bank ApS - Donor: 8847/Cyril
Safety warnings
|
Blood & Tissue
|
15/06/2026
The donor/the donor gametes have been permanently blocked.
European Sperm Bank ApS - Donor: 8847/Cyril
Read more
Urgent call for submission of QRD v.9 updates (June 2026)
messages in brief
|
08/06/2026
In accordance with Article 152 of Regulation (EU) 2019/6, all marketing authorisations for veterinary medicinal products (VMPs) granted under Directive 2001/82/EC, as amended, must be updated to align their product information with QRD template version 9.These updates must be completed at the latest by 29 January 2027, after which all products placed on the market must have product information compliant with QRD v9.
Urgent call for submission of QRD v.9 updates (June 2026)
Read more
Safety information on the quality defect/recall of “Convulex 50 mg/ml - Sirup für Kinder”
Safety warnings
|
Medicines
|
29/05/2026
Precautionary batch recall, as there may be glass splinters in the bottles
Safety information on the quality defect/recall of “Convulex 50 mg/ml - Sirup für Kinder”
Read more
Convulex 50 mg/ml - Sirup für Kinder
Recall
|
Medicines
|
29/05/2026
Recall due to possible contamination with glass splinters
Convulex 50 mg/ml - Sirup für Kinder
Read more
Atofab 10 mg-Hartkapseln
Recall
|
Medicines
|
29/05/2026
Recall due to reduced release of active pharmaceutical ingredient
Atofab 10 mg-Hartkapseln
Read more
Peptides - Illegal products from the internet with incalculable health risks
Enforcement
|
27/05/2026
Many of the offered "peptides" are classified as medicinal products without marketing authorisation by the Austrian Federal Office for Safety in Health Care (BASG) depending on their composition, concentration, effects and scientific data.
Peptides - Illegal products from the internet with incalculable health risks
Read more
Various GLP-1 products
Enforcement
|
27/05/2026
The BASG warns against illegal medicinal products (illegal medicinal product by presentation) marketed under the misleading name "GLP-1" because of their claims.
Various GLP-1 products
Read more
